The effects of dipivalyl epinephrine on the eye

Am J Ophthalmol. 1976 Jun;81(6):768-72. doi: 10.1016/0002-9394(76)90360-3.

Abstract

We treated one eye each of ten patients with ocular hypertension with dipivalyl epinephrine (DPE), a congener of epinephrine. Pupil size and intraocular pressure were measured before and at intervals up to 240 minutes after instillation of a single drop of DPE in concentrations from 0.005 to 0.5%. Concentrations of 0.025% DPE and greater significantly reduced IOP, and mydriasis was induced by concentrations of 0.1% DPE or greater. Comcentrations of 0.1% DPE, instilled twice daily for one month, significantly reduced intraocular pressure during diurnal testing on days 2 and 31. No toxic side effects were noted. The DPE produced dose-related increases of cyclic adenosine monophosphate in the aqueous humor of rabbits.

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Aqueous Humor / analysis
  • Clinical Trials as Topic
  • Cyclic AMP / analysis
  • Dose-Response Relationship, Drug
  • Epinephrine / analogs & derivatives*
  • Epinephrine / pharmacology
  • Hemodynamics / drug effects
  • Humans
  • Intraocular Pressure / drug effects*
  • Pupil / drug effects*
  • Rabbits
  • Tonometry, Ocular

Substances

  • Cyclic AMP
  • Epinephrine